Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Real Time PCR-ARES PCR Methods

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Drug Resistant Bacterial Infection
Interventions
DIAGNOSTIC_TEST

ARES PCR

"Real time PCR assays will be used for the identification of infecting microorganisms and the drug resistance they carry that allow their identification, such as KPC, VIM, IMP, NDM, Acinetobacter OXA, Oxa48, MCR.~The validation of the method will be carried out in 100 (based on availability in Tropica Biobank) clinical samples: blood n=50 (positive, as for the negatives reference will be made to those already provided in the GENRES study) and rectal swabs ( positive n=40 and negative n=10) provided by the DITM. Sensitivity and specificity will be analyzed. As a reference for positivity and negativity data, reference will be made to routine diagnostic data obtained through standard operating procedures at the DITM laboratories."

Trial Locations (1)

37024

RECRUITING

IRCCS Sacro Cuore Don Calabria hospital, Negrar

All Listed Sponsors
lead

IRCCS Sacro Cuore Don Calabria di Negrar

OTHER